Ouro Medicines is dedicated to developing immune reset therapeutics for people living with chronic immune-mediated diseases. Our approach is focused on leveraging T cell engagers in B cell mediated diseases to achieve immune resets that enable durable remissions without ongoing immunosuppression for patients. Based in San Francisco, Ouro was founded by Monograph Capital in partnership with GSK. We are also backed by leading investors TPG, NEA, Norwest and more.

Biotechnology

Health Care

Therapeutics

Ouro Medicines

Ouro Medicines' headquarters in San Francisco, United States

Jaideep Dudani

Christina Carlson

This department focuses on strategic decision-making and guiding the organization's vision and direction.

Executive Leadership

This department oversees clinical operations and corporate development initiatives to enhance organizational growth and effectiveness.

Clinical and Corporate Development

This department oversees strategic portfolio management and the execution of technical operations.

Portfolio and Operations

This department oversees project execution and coordination across various functions to ensure timely delivery and compliance with standards.

Program Management

This department focuses on scientific research and the development of innovative biological solutions.

Ouro Medicines

Org chart

Teams

Executive Leadership

Clinical and Corporate Development

Portfolio and Operations

Program Management

Research and Development

Offices

Ouro Medicines

Org chart

Teams

Executive Leadership

Clinical and Corporate Development

Portfolio and Operations

Program Management

Research and Development

Offices

Related companies